QTTB Q1 2022 Earnings — Q32 Bio Inc. Revenue & Financial Results | Market Cap Arena

QTTBQ32 Bio Inc.

$73M

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$802,000-97.3% YoY

Gross Profit

$257,00032.0% margin

Operating Income

-$38M-4690.5% margin

Net Income

$92M11484.4% margin

EPS (Diluted)

$28.65

QoQ Revenue Growth

+0.0%

Cash Flow

Operating Cash Flow

-$31M

Free Cash Flow

-$32M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$311M

Total Liabilities

$45M

Stockholders' Equity

$266M

Cash & Equivalents

$248M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$802,000	$29M	-97.3%
Gross Profit	$257,000	$0	—
Operating Income	-$38M	-$1M	-3286.0%
Net Income	$92M	-$1M	+8683.9%